Effect of celecoxib and L-NAME on global ischemia-reperfusion injury in the rat hippocampus

References

• Amantea D, Nappi G, Bernardi G, et al. (2009). Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J 276:13–26
   PubMed Web of Science ®Google Scholar
• Candelario-Jalil E, Alvarez D, Castaneda JM, et al. (2002). The highly selective cyclooxygenase-2 inhibitor DFU is neuroprotective when given several hours after transient cerebral ischemia in gerbils. Brain Res 927:212–15
   PubMed Web of Science ®Google Scholar
• Candelario-Jalil E, González-Falcón A, García-Cabrera M, et al. (2003). Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia. J Neurochem 86:545–55
   PubMed Web of Science ®Google Scholar
• Choi JS, Kim HY, Chun MH, et al. (2006). Differential regulation of cyclooxygenase-2 in the rat hippocampus after cerebral ischemia and ischemic tolerance. Neurosci Lett 393:231–6
   PubMed Web of Science ®Google Scholar
• Chu K, Jeong SW, Jung KH, et al. (2004). Celecoxib induces functional recovery after intracerebral hemorrhage with reduction of brain edema and perihematomal cell death. J Cereb Blood Flow Metab 24:926–33
   PubMed Web of Science ®Google Scholar
• Ciceri P, Zhang Y, Shaffer AF, et al. (2002). Pharmacology of celecoxib in rat brain after kainate administration. J Pharmacol Exp Ther 302:846–52
   PubMed Web of Science ®Google Scholar
• Crofford LJ, Lipsky PE, Brooks P, et al. (2000). Basic biology and clinical application of specific cyclooxygenase-2 inhibitors. Arthritis Rheum 43:4–13
   PubMed Web of Science ®Google Scholar
• Deb P, Sharma S, Hassan KM. (2010). Pathophysiologic mechanisms of acute ischemic stroke: an overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiology 17:197–218
   PubMedGoogle Scholar
• Ding-Zhou L, Marchand-Verrecchia C, Croci N, et al. (2002). L-NAME reduces infarction, neurological deficit, and blood-brain barrier disruption following cerebral ischemia in mice. Eur J Pharmacol 457:137–46
   PubMed Web of Science ®Google Scholar
• Doyle KP, Simon RP, Stenzel-Poore MP. (2008). Mechanisms of ischemic brain damage. Neuropharmacology 55:310–18
   PubMed Web of Science ®Google Scholar
• Endres M, Namura S, Shimizu-Sasamata M, et al. (1998). Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J Cereb Blood Flow Metab 18:238–47
   PubMed Web of Science ®Google Scholar
• Frampton JE, Keating GM. (2007). Celecoxib: a review of its use in the management of arthritis and acute pain. Drugs 67:2433–72
   PubMed Web of Science ®Google Scholar
• Funakoshi-Tago M, Shimizu T, Tago K, et al. (2008). Celecoxib potently inhibits TNF alpha-induced nuclear translocation and activation of NF-kappaB. Biochem Pharmacol 76:662–71
   PubMed Web of Science ®Google Scholar
• Futaki N, Harada M, Sugimoto M, et al. (2009). The importance of brain PGE2 inhibition versus paw PGE2 inhibition as a mechanism for the separation of analgesic and antipyretic effects of lornoxicam in rats with paw inflammation. J Pharm Pharmacol 61:607–14
   PubMed Web of Science ®Google Scholar
• Galvão RI, Diógenes JP, Maia GC, et al. (2005). Tenoxicam exerts a neuroprotective action after cerebral ischemia in rats. Neurochem Res 30:39–46
   PubMed Web of Science ®Google Scholar
• Gaur V, Aggarwal A, Kumar A. (2009). Protective effect of naringin against ischemic reperfusion cerebral injury: possible neurobehavioral, biochemical and cellular alterations in rat brain. Eur J Pharmacol 616:147–54
   PubMed Web of Science ®Google Scholar
• Gaur V, Kumar A. (2012). Effect of nonselective and selective COX-2 inhibitors on memory dysfunction, glutathione system, and tumor necrosis factor alpha level against cerebral ischemia reperfusion injury. Drug Chem Toxicol 35:218–24
   PubMed Web of Science ®Google Scholar
• Gopez J, Yue H, Vasudevan R, et al. (2005). Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury. Neurosurgery 56:590–604
   PubMed Web of Science ®Google Scholar
• Greco R, Mangione A, Amantea D, et al. (2011). IkappaB-alpha expression following transient focal cerebral ischemia is modulated by nitric oxide. Brain Res 1372:145–51
   PubMed Web of Science ®Google Scholar
• Guan QH, Pei DS, Liu XM, et al. (2006). Neuroprotection against ischemic brain injury by SP600125 via suppressing the extrinsic and intrinsic pathways of apoptosis. Brain Res 1092:36–46
   PubMed Web of Science ®Google Scholar
• Iadecola C, Xu X, Zhang F, et al. (1994). Prolonged inhibition of brain nitric oxide synthase by short-term systemic administration of nitro-L-arginine methyl ester. Neurochem Res 19:501–5
   PubMed Web of Science ®Google Scholar
• Jung KH, Chu K, Lee ST, et al. (2006). Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Neurobiol Dis 23:237–46
   PubMed Web of Science ®Google Scholar
• Kaloustian S, Wann B, Bah T, et al. (2007). Celecoxib after the onset of reperfusion reduces apoptosis in the amygdala. Apoptosis 12:1945–51
   PubMed Web of Science ®Google Scholar
• Kim DH, Kim S, Jung WY, et al. (2009). The neuroprotective effects of the seeds of Cassia obtusifolia on transient cerebral global ischemia in mice. Food Chem Toxicol 47:1473–9
   PubMed Web of Science ®Google Scholar
• Kirino T. (2000). Delayed neuronal death. Neuropathology 20:S95–7
   Google Scholar
• Koistinaho J, Koponen S, Chan PH. (1999). Expression of cyclooxygenase-2 mRNA after global ischemia is regulated by AMPA receptors and glucocorticoids. Stroke 30:1900–6
   PubMed Web of Science ®Google Scholar
• Kuluz JW, Prado RJ, Dietrich WD, et al. (1993). The effect of nitric oxide synthase inhibition on infarct volume after reversible focal cerebral ischemia in conscious rats. Stroke 24:2023–9
   PubMed Web of Science ®Google Scholar
• Li J, Han B, Ma X, et al. (2010a). The effects of propofol on hippocampal caspase-3 and Bcl-2 expression following forebrain ischemia–reperfusion in rats. Brain Res 1356:11–23
   PubMed Web of Science ®Google Scholar
• Li S, Wang W, Wang C, et al. (2010b). Possible involvement of NO/NOS signaling in hippocampal amyloid-beta production induced by transient focal cerebral ischemia in aged rats. Neurosci Lett 470:106–10
   PubMed Web of Science ®Google Scholar
• Liang HW, Qiu SF, Shen J, et al. (2008). Genistein attenuates oxidative stress and neuronal damage following transient global cerebral ischemia in rat hippocampus. Neurosci Lett 438:116–20
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–75
   PubMed Web of Science ®Google Scholar
• Maheshwari A, Badgujar L, Phukan B, et al. (2011). Protective effect of Etoricoxib against middle cerebral artery occlusion induced transient focal cerebral ischemia in rats. Eur J Pharmacol 667:230–7
   PubMed Web of Science ®Google Scholar
• Margaill I, Allix M, Boulu RG, Plotkine M. (1997). Dose- and time-dependence of L-NAME neuroprotection in transient focal cerebral ischaemia in rats. Br J Pharmacol 120:160–3
   PubMed Web of Science ®Google Scholar
• Moro MA, Cardenas A, Hurtado O, et al. (2004). Role of nitric oxide after brain ischaemia. Cell Calcium 36:265–75
   PubMed Web of Science ®Google Scholar
• Murphy S, Gibson CL. (2007). Nitric oxide, ischaemia and brain inflammation. Biochem Soc Trans 35:1133–7
   PubMed Web of Science ®Google Scholar
• Nakayama M, Uchimura K, Zhu RL, et al. (1998). Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc Natl Acad Sci U S A 95:10954–9
   PubMed Web of Science ®Google Scholar
• Nogawa S, Forster C, Zhang F, et al. (1998). Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc Natl Acad Sci U S A 95:10966–71
   PubMed Web of Science ®Google Scholar
• Nomura Y. (2004). Neuronal apoptosis and protection: effects of nitric oxide and endoplasmic reticulum-related proteins. Biol Pharm Bull 7:961–3
   Google Scholar
• Petito CK, Torres-Munoz J, Roberts B, et al. (1997). DNA fragmentation follows delayed neuronal death in CA1 neurons exposed to transient global ischemia in the rat. J Cereb Blood Flow Metab 17:967–76
   PubMed Web of Science ®Google Scholar
• Sancesario G, Iannone M, Morello M, et al. (1994). Nitric oxide inhibition aggravates ischemic damage of hippocampal but not of NADPH neurons in gerbils. Stroke 25:436–44
   PubMed Web of Science ®Google Scholar
• Sasaki T, Hamada J, Shibata M, et al. (2001). Inhibition of nitric oxide production during global ischemia ameliorates ischemic damage of pyramidal neurons in the hippocampus. Keio J Med 50:182–7
   PubMedGoogle Scholar
• Sasaki T, Kitagawa K, Yamagata K, et al. (2003). Amelioration of hippocampal neuronal damage after transient forebrain ischemia in cyclooxygenase-2-deficient mice. J Cereb Blood Flow Metab 24:107–13
   Web of Science ®Google Scholar
• Seif-el-Nasr M, Fahim A. (2001). Antioxidant effect of N omega-nitro-L-arginine methyl ester (L-NAME) on global cerebral ischemia in a rat model. Arzneimittelforschung 51:628–32
   PubMed Web of Science ®Google Scholar
• Sinn DI, Lee ST, Chu K, et al. (2007). Combined neuroprotective effects of celecoxib and memantine in experimental intracerebral hemorrhage. Neurosci Lett 411:238–42
   PubMed Web of Science ®Google Scholar
• Strauss K. (2008). Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain. Brain Behav Immun 22:285–98
   PubMed Web of Science ®Google Scholar
• Sugawara T, Fujimura M, Noshita N, et al. (2004). Neuronal death/survival signaling pathways in cerebral ischemia. Neuro Rx 1:17–25
   Google Scholar
• Takadera T, Yumoto H, Tozuka Y, Ohyashiki T. (2002). Prostaglandin E (2) induces caspase-dependent apoptosis in rat cortical cells. Neurosci Lett 317:61–4
   PubMed Web of Science ®Google Scholar
• Tracey WR, Tse J, Carter G. (1995). Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J Pharmacol Exp Ther 272:1011–15
   PubMed Web of Science ®Google Scholar